November 4, 2024
 
 

Small Stocks, Big Money™

Weekly Newsletter
REDCHIP.COM
 
 
ASP Isotopes Secures Agreement with Gates-Backed TerraPower for HALEU Production Facility
 
ASP Isotopes (Nasdaq: ASPI) signed a term sheet with TerraPower, an advanced nuclear energy technology company founded by Bill Gates. Under the anticipated agreement, TerraPower will fund the facility’s construction and enter a 10-year exclusive purchase commitment for all HALEU output, essential for fueling next-generation small modular reactors. This move leverages ASP’s proprietary, cost-efficient Quantum Enrichment technology, aiming to accelerate HALEU availability at lower capital costs. The facility, assigned to ASP's Quantum Leap Energy LLC, is set to meet the rising demand for advanced nuclear fuels as the world transitions toward carbon-free energy.
 
 
 
 
 
 
 
 
Gorilla Technology Projects Strong 2024 and Breakthrough Growth for 2025
 
Gorilla Technology (Nasdaq: GRRR) has set ambitious guidance, forecasting $72 million in 2024 revenue with EBITDA margins over 20% and projecting 2025 revenues to exceed $90 million. Fueled by a strong backlog of $93 million and new strategic contracts across Asia, MENA, and Latin America, Gorilla is rapidly expanding its global footprint. Its newly launched Gorilla Intelligent Network Director platform, targeting the $40 billion SD-WAN market, is poised to drive further gains. The company also continues a share repurchase program, reinforcing confidence in its valuation amid strong cash reserves and robust growth outlook.
 
 
 
 
 
 
 
GreenPower Secures $18.5M EPA-Funded Order for 50 All-Electric School Buses in West Virginia
 
GreenPower Motor Company (Nasdaq: GP) has finalized an $18.5 million order to supply 50 all-electric school buses—BEAST, Mega BEAST, and Nano BEAST models—to seven school districts in West Virginia, funded by the EPA’s Clean School Bus Program. The initiative will replace diesel buses with zero-emission alternatives, complete with a statewide charging infrastructure to support long and local routes. This deployment, part of GreenPower’s collaboration with local dealers and Highland Electric Fleet, highlights its growing footprint in the electric bus market, which aligns with new federal and California-based rebate programs for zero-emission school buses.
 
 
 
 
 
 
 
 
 
 
Alliance Entertainment Inks Exclusive Partnership with Magenta Light Studios
 
Alliance Entertainment’s (Nasdaq: AENT) Distribution Solutions division secured an exclusive deal with Magenta Light Studios to distribute their physical home entertainment releases in the U.S. and Canada. The partnership’s first release, Strange Darling, a horror thriller with a 95% rating on Rotten Tomatoes, will launch on DVD and Blu-ray on November 5, 2024. The partnership further strengthens Alliance Entertainment’s leadership in physical media distribution and aligns with the company’s strategic goal of expanding its portfolio of exclusive distribution agreements. Nearly 23% of Alliance Entertainment’s $1.1 billion revenue in fiscal year 2024 was generated from exclusive distribution agreements.
 
 
 
 
 
 
 
Phoenix Motor Reports Record $12M Revenue for Q2 2024
 
Phoenix Motor (Nasdaq: PEV) achieved a record $12.03 million in revenue for Q2 2024, marking a remarkable 937% increase year-over-year. With a gross profit of $1.83 million, the company reduced its net loss to $2.26 million, improved its cash reserves, and expanded total equity to $21.86 million. Key achievements include delivering five electric buses to UC Irvine, securing a contract with UC San Diego, and advancing its fourth-generation drivetrain. Under new leadership in operations and finance, Phoenix is positioned for further growth as it scales up to meet accelerating EV market demand.
 
 
 
 
 
 
 
Recent Research Coverage Updates
 
Company Rating Price Target Firm Report Date
ASP Isotopes (Nasdaq: ASPI) Buy $4.50 Cannacord Genuity October 4, 2024
LOBO EV (Nasdaq: LOBO) Buy $5 Zacks Small-Cap Research May 15, 2024
GreenPower Motor (Nasdaq: GP) Buy $1.65 Roth August 15, 2024
Enlivex Therapeutics (Nasdaq: ENLV) Buy $13 EF Hutton August 27, 2024
GreenPower Motor (Nasdaq: GP) Buy $3 RF Lafferty September 11, 2024
GreenPower Motor (Nasdaq: GP) Buy $5 Maxim July 2, 2024
GreenPower Motor (Nasdaq: GP) Hold n/a BTIG July 1, 2024
GreenPower Motor (Nasdaq: GP) Buy $3 Roth April 1, 2024
BioVie (Nasdaq: BIVI) Buy $3 ThinkEquity July 1, 2024
Calidi Biotherapeutics (NYSE American: CLDI) Buy $1 Ladenburg Thalman June 27, 2024
Calidi Biotherapeutics (NYSE American: CLDI) Buy $1 Rodman & Renshaw June 27, 2024
Calidi Biotherapeutics (NYSE American: CLDI) Buy $2 RW Baird May 14, 2024
Unusual Machines (NYSE American: UMAC) Buy n/a ThinkEquity June 17, 2024
Soligenix (Nasdaq: SNGX) n/a $4.15 Zacks Research June 14, 2024
Enlivex Therapeutics (Nasdaq: ENLV) Buy $6 HC Wainwright June 11, 2024
Sixty Degrees Pharma (Nasdaq: SXTP) Hold n/a HC Wainwright June 6, 2024
Sixty Degrees Pharma (Nasdaq: SXTP) Buy n/a Ascendiant May 21, 2024
American Resources (Nasdaq: AREC) Buy n/a HC Wainwright June 3, 2024
 
 
 
 
Small Stocks, Big Money™ Podcast
 
The podcast features in-depth interviews with CEO’s from the top names in small-cap stocks, providing listeners with a unique perspective not found anywhere else.
Available on:
amazon music apple music spotify music
 
 
 
 
 
 
Upcoming Events
 
 
5
 
 
Nov 2024
 
NASDAQ: NXL - Nexalin Technology
4:15pm Eastern
 
Nexalin designs and develops innovative neurostimulation products to uniquely help combat the ongoing global mental health epidemic.
 
 
 
 
 
 
 
6
 
 
Nov 2024
 
NASDAQ: BFRG - BullFrog AI
4:15pm Eastern
 
BullFrog AI is a technology enabled drug development company using machine learning to usher in a new era of precision medicine.
 
 
 
 
 
 
 
7
 
 
Nov 2024
 
NASDAQ: BIVI - BioVie Inc.
04:15pm Eastern
 
BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease.
 
 
 
 
 
 
 
Archived Events
 
 
30
 
 
Oct 2024
 
NYSE American: OSTX - OS Therapies
4:15pm Eastern
 
OS Therapies, a clinical stage biopharmaceutical company, is at the forefront of developing innovative treatments for Osteosarcoma (OS), breast cancer and other solid tumors.
 
 
 
 
 
 
 
29
 
 
Oct 2024
 
NYSE American: CANF - Can-Fite Biopharma
4:15pm Eastern
 
Can Fite Biofarma Ltd is an clinical-stage biopharmaceutical company. The company develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases.
 
 
 
 
 
 
 
28
 
 
Oct 2024
 
NASDAQ: LOBO - LOBO EV
4:15pm Eastern
 
LOBO EV, headquartered in Wuxi, China, is a pioneering OEM and ODM manufacturer and seller of electric vehicles (EVs), including e-bicycles, e-mopeds, e-tricycles, and electric off-highway four-wheeled shuttles, tailored for various demographics, including mobility solutions for the elderly and disabled.
 
 
 
 
 
 
Quote of the Week
 
"Don't put too much money in any one stock, spread it out, you never know which ones will be you big winner."
— Buzz Heidkte, MidSouth Investment Fund
 
 
RedChip TV
 
 
 
 
RedChip TV Highlights LOBO EV (NASDAQ: LOBO) & Nexalin Technology (NASDAQ: NXL)
 
 
 
 
 
 
 
Order "Small Stocks, Big Money™ Today!
 
Dave Gentry's new book, Small Stocks, Big Money: Interviews With Microcap Superstars, is now available for pre-order. Published by Wiley Finance, this first-hand perspective and insider information on the fast world of microcap investing is now available for purchase.
 
 
 
 
 
 
 
Lesson of the Week
 
This week we talk about value investing, a concept that originated more than 70 years ago by Benjamin Graham.
 
 
 
 
 
 
 
MidSouth Week in Review
 
U.S. economy adds 12,000 jobs in October, below expectations of 106,000. The unemployment rate was 4.1%.